Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07709052 is registered in ClinicalTrials.gov with Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis as lead sponsor.

NCT NCT07709052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07709052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)
Lead sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 1, 2028
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intraductal papillary mucinous neoplasm of pancreas, pancreatic ductal adenocarcinoma (pdac), pancreatic intraepithelial neoplasia